Cargando…
Influenza vaccination in high-risk groups: a revision of existing guidelines and rationale for an evidence-based preventive strategy
Influenza, an infectious respiratory disease, is one of the main causes of excess winter deaths (EWDs) in Europe. Annual flu epidemics are associated with high morbidity and mortality rates, especially among the elderly, those with underlying health conditions and pregnant women. Health Care Workers...
Autores principales: | Costantino, C., Vitale, F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pacini Editore SRL
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4910437/ https://www.ncbi.nlm.nih.gov/pubmed/27346934 |
Ejemplares similares
-
Revision of the ARRIVE guidelines: rationale and scope
por: Percie du Sert, Nathalie, et al.
Publicado: (2018) -
Influenza vaccines and influenza antiviral drugs in Africa: are they available and do guidelines for their use exist?
por: Duque, Jazmin, et al.
Publicado: (2014) -
Prioritization of Pandemic Influenza Vaccine: Rationale and Strategy for Decision Making
por: Schwartz, Benjamin, et al.
Publicado: (2009) -
Rationale for azithromycin in COVID-19: an overview of existing evidence
por: Gyselinck, Iwein, et al.
Publicado: (2021) -
The rationale for quadrivalent influenza vaccines
por: Ambrose, Christopher S., et al.
Publicado: (2012)